Records containing: Oculopharyngeal Muscular Dystrophy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-27Saliva Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)
-
CLINICAL_TRIALS study record update · 2025-12-31A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
-
CLINICAL_TRIALS study record update · 2022-05-27Natural History Study of Oculopharyngeal Muscular Dystrophy
-
CLINICAL_TRIALS study record update · 2022-04-21Interventional Study of Expiratory Muscle Strength Training as a Treatment in Neuromuscular Disorders
-
CLINICAL_TRIALS study record update · 2020-03-27Determination of Accurate Screening Tools for Dysphagia in Oculopharyngeal Muscular Dystrophy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-13A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Trial of Trehalose for the Treatment of
-
CLINICAL_TRIALS study record update · 2019-03-21Pathology Analysis of OPMD Patient Myotomies
-
CLINICAL_TRIALS study record update · 2017-08-23Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
-
CLINICAL_TRIALS study record update · 2014-06-06Effect of Aerobic Training in Patients With Oculopharyngeal Muscular Dystrophy